Pay in 4 interest-free payments of $27.23 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
and thereby prolonged action potential durations (APDs) and corrected QT interval (QTc) intervals
121345-64-0
Chemical Name: 2-[(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-sulfanylidene-1
Formula: C22H30O5
Emricasan Catalog No.:M10978-10 and thereby prolonged action potentialEmricasan, also known as IDN 6556 and PF 03491390, is a first in class caspase inhibitor in clinical trials for the treatment of liver diseases. Emricasan (IDN 6556) decreases liver injury and fibrosis in a murine model of non alcoholic steatohepatitis. IDN6556 facilitates marginal mass islet engraftment in a porcine islet autotransplant model. Oral IDN 6556 may lower aminotransferase activity in patients with chronic hepatitis C. Orally administered
US$ 20.00
US$ 10.00
US$ 19.99
US$ 39.90